Zopiclone

佐匹克隆

Report date: 2026/01/13 20:00:24
NME

Base Information

Drug NameZopiclone
Drug Alias Name吡嗪哌酯哇匹可隆唑匹可隆忆孟返Amoban +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAlcohol DrinkingSleep Initiation and Maintenance DisordersSleep Apnea, Obstructive
Global Approved IndicationsSleep Initiation and Maintenance Disorders
Approved Indications in ChinaSleep Initiation and Maintenance Disorders
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaFinlandEU +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesNichi-Iko Pharmaceutical Co LtdGuangdong Cr Shunfeng Pharmaceutical Co Ltd
Inactive CompaniesUniversity Of TurkuOsr Medical IncI.M. Sechenov First Moscow State Medical University
Active IndicationsSleep Initiation and Maintenance Disorders
Inactive IndicationsAlcohol DrinkingSleep Apnea, Obstructive

Other Information

ATC CodeN05CF01
Related LinksWikipediaDrugBankKEGG